newsJanuary 7, 20260 views
World-renowned Immunologist and Distinguished Scientist Joins CancerVax as Senior Scientific Advisor
Dr. Mark Davis, discoverer of the first T-cell receptor genes and Stanford Professor, to advise the Company on immunological strategies for its novel cancer treatment platform Dr. Mark Davis, discoverer of the first T-cell receptor genes and Stanford Professo…
CancerVAX, Inc
Dr. Mark Davis, discoverer of the first T-cell receptor genes and Stanford Professor, to advise the Company on immunological strategies for its novel cancer treatment platform Dr. Mark Davis, discoverer of the first T-cell receptor genes and Stanford Professo…
Read Full Article
Opens in a new tab
Related Articles
news
Starfleet Academy spoiler-free review: I'm hugely surprised by Star Trek's new Discovery spinoff
January 8, 2026
news
PathAI and University Hospital Zurich Announce Collaboration to Deploy AISight® Dx and AIM-TumorCellularity for Routine Molecular Pathology Workflows
January 8, 2026
news
What Do We Actually Mean by "AI-Powered Search"? [Aaron Tay's Musings about Librarianship]
January 8, 2026